EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort

Masahiro Yamashita, Kiichiro Ninomiya, Shuta Tomida, Eiji Nakata, Ayako Morita, Naofumi Hara, Kenji Takada, Go Makimoto, Toshio Kubo, Eiki Ichihara, Kadoaki Ohashi, Katsuyuki Hotta und 3 weitere

European Journal of Cancer · 2026-11 · 248 · 117443

DOI: 10.1016/j.ejca.2026.117443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Masahiro Yamashita und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Mutation. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsErb-b2 Receptor Tyrosine KinasesMutationBiomarkers, TumorHumansJapanFemaleMaleAgedRetrospective StudiesMiddle AgedAged, 80 and overAdultTrastuzumabEast Asian PeopleCamptothecinImmunoconjugates

Stichwörter der Autor:innen

Comprehensive genomic profilingERBB2 mutationNon-small cell lung cancerTrastuzumab-deruxtecanVariant subtype

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, humanBiomarkers, Tumortrastuzumab deruxtecanTrastuzumabCamptothecinImmunoconjugates

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan; Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan. Electronic address: kiichiro_nino@okayama-u.ac.jp.
  • Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan.
  • Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan; Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, J…
  • Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan; Advanced Research Field, Institute for Emerging Medical Innovation, Okayama University, Okayama, Japan; Department of Tumor Microenvironme…
  • Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmace…

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yamashita, M., Ninomiya, K., Tomida, S., Nakata, E., Morita, A., Hara, N., Takada, K., Makimoto, G., Kubo, T., Ichihara, E., Ohashi, K., Hotta, K., Togashi, Y., Maeda, Y., & Ennishi, D. (2026). Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort. European Journal of Cancer, 248, 117443. https://doi.org/10.1016/j.ejca.2026.117443

Vancouver

Yamashita M, Ninomiya K, Tomida S, Nakata E, Morita A, Hara N, et al. Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort. European Journal of Cancer. 2026;248:117443. doi:10.1016/j.ejca.2026.117443

BibTeX
@article{Yamashita2026,
  author = {Yamashita, Masahiro and Ninomiya, Kiichiro and Tomida, Shuta and Nakata, Eiji and Morita, Ayako and Hara, Naofumi and Takada, Kenji and Makimoto, Go and Kubo, Toshio and Ichihara, Eiki and Ohashi, Kadoaki and Hotta, Katsuyuki and Togashi, Yosuke and Maeda, Yoshinobu and Ennishi, Daisuke},
  title = {Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117443},
  doi = {10.1016/j.ejca.2026.117443}
}
Kostenlos starten →